(Toronto) The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, September 11, 2016

(Toronto) The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma



abstract

Highlights

  • Clear cell carcinoma of the ovary is a rare subtype which is relatively resistant to platinum based chemotherapy.
  • Ovarian clear cell carcinoma is frequently diagnosed at early stage, the role of adjuvant treatment is disputable.
  • Our study did not demonstrate a survival benefit for adjuvant radiation in patients with ovarian clear cell carcinoma.

Abstract

Objective

To assess the impact of adjuvant radiotherapy (RT) on survival in patients with stage I and II ovarian clear cell carcinoma (OCCC).

Methods

Data collection and analysis of stage I and II OCCC patients treated at two tertiary centers in Toronto, between 1995 and 2014, was performed. Descriptive statistics and Kaplan-Meier survival probability estimates were completed. The log-rank test was used to compare survival curves.

Results

163 patients were eligible. 44 (27%) patients were treated with adjuvant RT: 37 of them received adjuvant chemotherapy (CT), and 7 had RT only. In the no-RT group, there were 119 patients: 83 patients received adjuvant CT and 36 had no adjuvant treatment. The 10 year progression free survival (PFS) was 65% for patients treated with RT, and 59% no-RT patients. There were a total of 41 (25%) recurrences in the cohort: 12 (27.2%) patients in RT group and 29 (24.3%) in the no-RT group. On multivariable analysis, adjuvant RT was not significantly associated with an increased PFS (0.85 (0.44–1.63) p = 0.63) or overall survival (OS) (0.84 (0.39–1.82) p  = 0.66). In the subset of 59 patients defined as high-risk: stage IC with positive cytology and/or surface involvement and stage II: RT was not found to be associated with a better PFS (HR 1.18 (95% CI: 0.55–2.54) or O S(HR 1.04 (95% CI: 0.40–2.69)).

Conclusion

Adjuvant RT was not found to be associated with a survival benefit in patients with stage I and II ovarian clear cell carcinoma or in a high risk subset of patients including stage IC cytology positive/surface involvement and stage II patients.

1 comment :

  1. NOTE: (STATS) post 2014: 1 pt (1C) radiation alone died in 2015 (colorectal cancer) no Lynch syndrome mutation found

    ReplyDelete

Your comments?

1 comment :

  1. NOTE: (STATS) post 2014: 1 pt (1C) radiation alone died in 2015 (colorectal cancer) no Lynch syndrome mutation found

    ReplyDelete

Your comments?